The Quantellect read.As of Nov 19, 2026, 12 active firms cover ArcBest Corp: 7 rate it Buy or better, 5 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets range widely, $84.00 to $180.00 (about 2.1x), a sign of real disagreement on valuation. The average target of $150.25 sits 12% above the current $134.13. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees revenue growth near 9% this year and 6% next, consensus EPS building from about $1.40 next quarter toward $9.73 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS12 active firms
Buy
Strong Buy00%
Buy758%
Neutral542%
Sell00%
Strong Sell00%
Based on 12 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$150.25
+12.0% upside
Average target across 12 active firms as of Nov 19, 2026 vs $134.13 current
Highest Target$180.00
Average Target$150.25
Lowest Target$84.00
Detailed analyst forecasts for ARCB
Showing 1–13 of 13 named analysts shown · 12 active firms in the rating projection
As of Nov 19, 2026, 7 of 12 active firms rate ARCB a Buy (5 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
ARCB EPS & revenue forecast
EPS · NEXT QUARTER
$1.40
Range $1.12 – $1.58 · 10 analysts · +338% YoY
Next period, 10 analysts expect ArcBest Corp to earn $1.40 a share (range $1.12 – $1.58), versus $0.32 a year earlier. Full-year consensus is $7.38, growing to $9.73 the year after.
REVENUE · NEXT QUARTER
$1.1B
Range $1.1B – $1.2B · 10 analysts · +9% YoY
Revenue is expected to reach $1.1B (range $1.1B – $1.2B), +9.0% year-over-year. Full-year consensus is $4.6B, rising to $4.9B next year.
Top analysts covering ArcBest Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ARCB.
#1
Thomas Wadewitz
UBS · Rank #153
Neutral
$154.00+14.8% to target
Overall win rate
42%
+ Follow
#2
Ken Hoexter
B of A Securities · Rank #269
Neutral
$151.00+12.6% to target
Overall win rate
46%
+ Follow
#3
Brian Ossenbeck
JP Morgan · Rank #383
Neutral
$158.00+17.8% to target
Overall win rate
37%
+ Follow
#4
Stephanie Moore
Jefferies · Rank #462
Buy
$125.00-6.8% to target
Overall win rate
37%
+ Follow
#5
Ariel Rosa
Citigroup
Buy
$170.00+26.7% to target
Coverage
—
+ Follow
ARCB stock forecast FAQ
What is ARCB's average 12-month price target?+
The 12 active firms with a live target average $150.25 for ArcBest Corp over the next 12 months, ranging from a $180.00 high to a $84.00 low, as of Nov 19, 2026.
Is ARCB stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 12 active firms as of Nov 19, 2026, 7 rate it Buy or Strong Buy, 5 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for ARCB?+
The Street-high target is $180.00 (Citizens), and the Street-low is $84.00 (B of A Securities). The average of all 12 active-firm targets is $150.25.
How many active Wall Street firms cover ARCB?+
12 active firms have a recognized rating on ArcBest Corp as of Nov 19, 2026, and 12 active firms carry a live 12-month price target.
Who is the most accurate analyst covering ARCB?+
Among analysts who currently cover ARCB, Thomas Wadewitz of UBS has the strongest overall Quantellect track record (Rank #153). Their current call is Neutral with a $154.00 target.
What is ArcBest Corp's projected EPS for next quarter?+
The consensus estimate is $1.40 per share (range $1.12 – $1.58) across 10 analysts. Full-year EPS is projected at $7.38, rising to $9.73 the following year.
How much revenue is ArcBest Corp expected to report next quarter?+
Consensus revenue is $1.1B (range $1.1B – $1.2B). Full-year revenue is projected at $4.6B, growing to $4.9B next year.
Have analysts been upgrading or downgrading ARCB lately?+
As of Nov 19, 2026, 7 of 12 active firms rate ARCB a Buy (5 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ARCB calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.